Publication information
Commercial disclosure
The first position is a publishing decision.
How CoreAge appears
The Salicylic Standard is part of the CoreAge Rx promotional publishing network. CoreAge receives the first commercial position in the comparison and a feature in every article. This is a disclosed commercial order, not a finding of clinical superiority.
How offer links are identified
The Pore Favor offer uses the referring domain, referral channel, campaign and article slug as UTM parameters. Its link carries sponsored and nofollow attributes. A provider destination processes the visit under its own policies; its actual transaction and clinical decisions are separate from this publication.
What is not being claimed
No particular commission rate, legal ownership structure, clinical endorsement or firsthand use is claimed. Placement cannot establish personal eligibility or a prescription decision. The review keeps unresolved formula details, actual quantities, label versions and order-specific terms alongside the commercial record.